Acetylenic carbamate in childhood cancer.
D000208:Acute Disease; D000293:Adolescent; D000367:Age Factors; D000480:Alkynes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001772:Blood Cell Count; D001859:Bone Neoplasms / Q000188:drug therapy; D002219:Carbamates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003510:Cyclohexanes / Q000627:therapeutic use; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*; D009455:Neurofibroma / Q000188:drug therapy; D012516:Osteosarcoma / Q000188:drug therapy; D012208:Rhabdomyosarcoma / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D009396:Wilms Tumor / Q000188:drug therapy
D000480:Alkynes; D002219:Carbamates; D003510:Cyclohexanes; D006454:Hemoglobins